Netherlands· NL-97204f8872d9

Pentoxifylline Medcor 400 mg, tabletten met gereguleerde afgifte

A pentoxifylline product containing pentoxifylline, registered in Netherlands by Medcor Pharmaceuticals B.V.. The same ATC class is registered in 12 of our 19 countries.

ATC C04AD03

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about pentoxifyllineAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Pentoxifylline is registered in 12 of 19 countries.

Countries holding a registration under ATC C04AD03 (pentoxifylline), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
7 of them publish a price we can compare per daily dose

Search pentoxifylline products by name

Pentoxifylline · ATC C04AD03

12 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Netherlands
Norwayprice
Polandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)

Active substance: PENTOXIFYLLINE
Manufacturer: Medcor Pharmaceuticals B.V.
Country: Netherlands (NL)
ATC code: C04AD03
ATC class: Pentoxifylline
Defined daily dose: 1 g, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
132826//11175

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

435 interactions on record for pentoxifylline.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check pentoxifylline against other medicines How interaction checks work

Pentoxifylline · interactions on record

435 records

4 severe
252 moderate
179 info

Most severe, free to view

CimetidineA02BA01moderate
PapaverineA03AD01moderate
Obeticholic acidA05AA04moderate
MannitolA06AD16moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Pentoxifylline in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pentoxifylline products

Authorised across Europe · EMA

The same active substance is authorised in 23 EEA countries. Names it is sold under:

Austria · Pentomer Retard, Pentoxi Retard
Belgium · Torental
Bulgaria · Агапурин, Агапурин Sr
Cyprus · Angiopent Retard, Tarοntal
Czechia · Agapurin, Pentomer Retard
Germany · Pentoxifyllin 1 A Pharma, Pentoxifyllin Ratiopharm
Estonia · Pentilin, Vasonit Retard
Spain · Elorgan, Hemovás
France · Pentoxifylline Lp Biogaran, Pentoxifylline Lp Eg
United Kingdom (Northern Ireland) · Pentoxifylline Neuraxpharm Uk
Greece · Tarontal
Croatia · Pentilin, Trental
Hungary · Chinotal, Pentoxyl
Italy · Trental
Lithuania · Agapurin, Pentilin
Luxembourg · Pentoxifylline Ratiopharm, Torental
Latvia · Pentilin, Polfilin
Norway · Trental
Poland · Agapurin, Agapurin Sr
Portugal · Pentoxifilina Generis, Trental
Romania · Angiopent Retard, Pentoxi Retard
Slovenia · Pentilin
Slovakia · Agapurin, Agapurin Sr

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/3e42f2b9-6ca7-4234-9ae4-87b88d7e345a
GET /v1/drugs/3e42f2b9-6ca7-4234-9ae4-87b88d7e345a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet met gereguleerde afgifte",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h11175_smpc.pdf",
  "strength": null,
  "atc_label": "Pentoxifylline",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg132826",
  "excipients": [
    "ERYTHROSINE (E 127)",
    "HYDROXYETHYLCELLULOSE",
    "HYPROMELLOSE (E 464)",
    "MACROGOL 8000",
    "MAGNESIUMSTEARAAT (E 470b)",
    "POVIDON K 25 (E 1201)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "PENTOXIFYLLINE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h132826.pdf",
  "authorised_at": "2024/05/23",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "132826//11175",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about pentoxifylline.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console